Navigating Bladder Cancer Recurrence: Surveillance and Beyond | Part 2
Dealing with low-grade non-muscle invasive bladder cancer (NMIBC) can be a journey filled with uncertainties. While some patients undergo successful tumor removal with no recurrence, many face the challenge of managing reappearances. In this BCAN webinar, urologists, Yair Lotan, MD and Eila Skinner, MD, shed light on crucial aspects of bladder cancer recurrence, surveillance, and the steps beyond.
▶︎
Navigating Bladder Cancer Recurrence: Surveillance and Beyond | Part I
▶︎
Navigating Bladder Cancer Recurrence: Surveillance and Beyond | Part 3
▶︎
Webinar: Exploring Rare Types of Bladder Cancer Part 2 of 4.
▶︎
Bladder Cancer: NON-Muscle Invasive (Superficial Bladder Cancer)
▶︎
Oncogenetics - Mechanism of Cancer (tumor suppressor genes and oncogenes)
▶︎
What's in your Bladder Cancer Pathology Report?
▶︎
Posture, Bone Density & Muscle: A Stanford Doctor Destroys Aging Myths Most People Believe
▶︎
Overcoming the Undruggable Nature of the Most Common Human Oncogene K-Ras
▶︎
Recurrence of Non Muscle Invasive Bladder Cancer
▶︎
Managing Side Effects of Procedures and Treatments in the Bladder from a Medical Perspective
▶︎
Webinar: Exploring Rare Types of Bladder Cancer Part 3 of 4.
▶︎
Management of Non-Muscle Invasive Bladder Cancer
▶︎
Urinary Markers in Bladder Cancer
▶︎
Treating Small Cell Lung Cancer in 2025 and Beyond
▶︎
Introduction to Suture
▶︎
The Devastating Effects Of Stage 4 Cancer
▶︎
Non-Muscle Invasive Bladder Cancer Treatment Dilemmas (2025)
▶︎
New bladder cancer treatment would keep bladder intact
▶︎
Management of High-Grade T1 Bladder Cancer
▶︎